Basic Materials / ChemicalsNYSE
$8.66
+0.63 (+7.77%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $-77.0M · quality 25.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
25/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.4B
P/E
N/A
•EV/EBITDA
217.4x
↑ROE
-33.1%
↓Gross Margin
9.3%
↓Debt/Equity
2.39
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2011–2025 · 14 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
—
FCF margin
-9.7%
FCF / Net income
0.60x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.90B · net income $-470.0M · FCF $-281.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||
| Revenue | $2.90B | $2.90B | $3.07B | $2.85B | $3.45B | $3.57B | $2.76B | $2.64B | $1.82B | $1.70B | $1.31B | — | — | — | — | — |
| Net Income | $-470.0M | $-470.0M | $-48.0M | $-316.0M | $497.0M | $286.0M | $969.0M | $-109.0M | $-7.0M | $-285.0M | $-61.0M | $-329.0M | $-427.0M | $-126.0M | $1.13B | $242.0M |
| EBITDA | $21.0M | $21.0M | $515.0M | $473.0M | $694.0M | $874.0M | $575.0M | $375.0M | $395.0M | $323.0M | $124.0M | $52.0M | $295.0M | $336.0M | $236.0M | — |
| EPS | -2.97 | -2.97 | -0.31 | -2.02 | 3.16 | 1.81 | 6.69 | -0.78 | -0.06 | — | — | -2.75 | -3.74 | -1.11 | 11.10 | — |
| Gross Margin | 9.3% | 9.3% | 16.8% | 16.2% | 24.1% | 25.1% | 22.5% | 17.6% | 27.4% | 22.9% | 10.2% | — | — | — | — | — |
| Operating Margin | -0.7% | -0.7% | 7.1% | 6.5% | 15.7% | 16.2% | 9.8% | 3.6% | 11.0% | 8.3% | -4.0% | — | — | — | — | — |
| Net Margin | -16.2% | -16.2% | -1.6% | -11.1% | 14.4% | 8.0% | 35.1% | -4.1% | -0.4% | -16.8% | -4.7% | — | — | — | — | — |
| Balance Sheet | ||||||||||||||||
| Debt/Equity | 2.39 | 2.39 | 1.70 | 1.52 | 1.13 | — | — | — | — | — | 2.86 | 2.92 | 1.48 | 1.07 | 0.61 | — |
| Current Ratio | 2.42 | 2.42 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||
| Free Cash Flow | $-281.0M | $-281.0M | $-70.0M | $-77.0M | $170.0M | — | — | — | — | — | — | — | — | — | — | — |
| Returns | ||||||||||||||||
| ROE | -33.1% | -33.1% | -2.7% | -16.3% | 21.1% | 14.3% | 57.1% | -14.6% | -1.0% | -34.4% | -6.0% | -33.0% | -26.5% | -5.6% | 42.8% | — |
| Valuation | ||||||||||||||||
| P/E | — | — | — | — | 4.94 | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 217.44 | 217.44 | 8.42 | 9.97 | 7.14 | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 0.97 | 0.97 | 0.85 | 1.05 | 1.04 | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||
| Revenue Growth | -5.7% | -5.7% | 7.9% | -17.5% | — | 29.5% | 4.4% | 45.2% | 7.1% | 29.7% | — | — | — | — | — | — |
| EPS Growth | -858.1% | -858.1% | 84.7% | -163.9% | — | -72.9% | 957.7% | -1200.0% | — | — | — | 26.5% | -236.9% | -110.0% | — | — |
| Dividend Yield | 2.5% | 2.5% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+63.5%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.31 → -2.97
Residual
+61.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.